XML 49 R5.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Capital stock
Reserves
Deficit
Beginning balance (in shares) at Dec. 31, 2021 105,359,211      
Beginning balance at Dec. 31, 2021 $ 110,878 $ 181,857 $ 17,804 $ (88,783)
Changes in equity [abstract]        
Shares issued for royalty and property acquisitions (in shares) 211,795      
Shares issued for royalty and property acquisitions $ 477 477    
Shares issued for private placements (in shares) 3,812,121      
Shares issued for private placements $ 10,000 8,670 1,330  
Share issue costs $ (39) (39) 0  
Shares issued for exercise of stock options (in shares) 1,110,000      
Shares issued for exercise of stock options $ 1,037 1,639 (602)  
RSUs issued (in shares) 171,063      
RSUs issued $ 0 402 (402)  
Share-based payments 3,429   3,429  
Foreign currency translation adjustment (5,930)   (5,930)  
Effect of functional currency change 0   (3,876) 3,876
Income (loss) for the year $ 3,349     3,349
Ending balance (in shares) at Dec. 31, 2022 110,664,190      
Ending balance at Dec. 31, 2022 $ 123,201 193,006 11,753 (81,558)
Changes in equity [abstract]        
Shares issued for exercise of stock options (in shares) 1,314,000      
Shares issued for exercise of stock options $ 1,283 2,037 (754)  
RSUs issued (in shares) 255,850      
RSUs issued $ (198) 1,001 (1,199)  
Share-based payments 2,068   2,068  
Reclass of warrants to derivative liability (1,286)   (1,286)  
Foreign currency translation adjustment 0      
Effect of functional currency change 0 (35,131) 8,038 27,093
Income (loss) for the year $ (4,633)     (4,633)
Ending balance (in shares) at Dec. 31, 2023 112,234,040      
Ending balance at Dec. 31, 2023 $ 120,435 $ 160,913 $ 18,620 $ (59,098)